Phathom Pharmaceuticals Inc (PHAT)

Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.682	-	-	-	-
Operating Expenses	97.40% 70.39	35.66	31.70	30.08	46.64
Interest Income/Expense	28.91% 13.03	10.11	9.615	9.217	9.602
Operating Income/Loss	95.95% -69.88	-35.66	-31.70	-30.08	-46.64
Nonoperating Income/Loss	27.83% -9.695	-7.584	-9.264	-7.737	-8.405
Income/Loss From Continuing Operations Before Tax	84.01% -79.57	-43.24	-40.97	-37.81	-55.05
Income/Loss From Continuing Operations After Tax	84.01% -79.57	-43.24	-40.97	-37.81	-55.05
Net Income/Loss	84.01% -79.57	-43.24	-40.97	-37.81	-55.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	96.44% 2.0238	56.78	48.50	42.35	0.7389
Diluted Average Shares	96.44% 2.0238	56.78	48.50	42.35	0.7389
Basic Earnings Per Share	90.79% -1.45	-0.76	-0.84	-0.89	-1.33
Diluted Earnings Per Share	90.79% -1.45	-0.76	-0.84	-0.89	-1.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-